ACI’s Hatch-Waxman and BPCIA Proficiency Series
07 October 2021
Partner Steve Maebius will present on a panel titled, “Small and Large Molecule Drug Patents and Other Related IP Protections and Mechanisms,” on Thursday, October 7, 2021 during ACI’s upcoming virtual three-week program. The program will provide an in-depth review of the IP basics relative to small molecules and biologics, as well as the regulation and litigation fundamentals of the Hatch-Waxman and Biologics Price Competition and Innovation (BPCIA) Acts.
Steve and his fellow panelists will discuss patent protections for drugs and biologics as well as trademark, trade name, and trade dress protections. The topics to be discussed include:
- Patent process for drugs and biologics
- Strategies for protecting patents for drugs and biologics
- Applying for and achieving extensions of patent terms for time spent in the drug approval process
- Patent Term Extension (“PTE”) and Patent Term Adjustment (“PTA”)
- The 271(e)(1) “safe harbor” provision
- Differences between the patenting process for drugs and biologics
- Selecting a brand name for a proposed drug product
- Duties of USPTO and FDA in drug naming process
- PTO and FDA clearances necessary for trade name and trademark approval of a product
- Importance of trade dress
- Branding process for a product
For more information and to register please visit the program website.
Author(s)
Related Insights
06 May 2024
Labor & Employment Law Perspectives
Update: Supreme Court Revises Title VII’s Decades-Old “Adverse Employment Action” Standard for Discriminatory Transfers
In January 2024, we reported on a significant case, Muldrow v. City of St. Louis, Missouri, No. 22-193, which was then pending before the United States Supreme Court. On April 17, 2024, the Court issued its decision in this case and, in doing so, modified the standard required to prove employment discrimination under Title VII of the Civil Rights Act of 1964 with respect to job transfers.
06 May 2024
Labor & Employment Law Perspectives
EEOC’s New Harassment Enforcement Guidelines: A Good Primer for Addressing Workplace Harassment and Retaliation
On April 29, 2024, the Equal Employment Opportunity Commission issued its long-awaited workplace harassment and enforcement guidelines to help employers understand what type of conduct the agency considered to be unlawful harassment.
06 May 2024
Article
Federal Court Protects Franchisor’s Rights Pursuant to Clear Terms of Franchise Agreement
In Bank United, NA v. GC of Vineland, LLC, Karen and William Scism and GC Vineland, LLC filed a complaint in the U.S. District Court for the District of New Jersey against Golden Corral Corporation and Golden Corral Franchising Systems Inc.